Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

Clinical Trial

Offered by: Nemours Children's
Locations: Delaware Valley and Jacksonville, Orlando and Pensacola in Florida

Trial Name

Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

What is the trial about?

Compares the effects (good and/or bad) of a medicine called modafinil to a placebo (no active medicine).

Who can participate?

Patients who have been treated for a primary brain tumor with surgery, chemotherapy and/or radiation therapy.

What is involved?

• The study will last a maximum of 10 weeks. 
• Your child will take modafinil or placebo daily for 6 weeks. Then he/she will repeat tests that were given before starting study medicine.
• 30 days later the study staff will see how he/she is doing.